These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21603831)

  • 41. Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchange.
    Disler P; Day R; Burman N; Blekkenhorst G; Eales L
    Am J Med; 1982 Jun; 72(6):989-93. PubMed ID: 7091165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 43. Porphyria cutanea tarda-like dermatosis by hemodialysis. Ultrastructural study of exposed skin.
    Perrot H; Germain D; Euvrard S; Thivolet J
    Arch Dermatol Res (1975); 1977 Aug; 259(2):177-85. PubMed ID: 907367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic hemodialysis-related porphyria/pseudoporphyria].
    Kószó F; Földes M; Morvay M; Judák R; Vakis G; Dobozy A
    Orv Hetil; 1994 Sep; 135(39):2131-6. PubMed ID: 7936621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
    Þorsteinsdóttir S; Velander MJ; Bygum A
    Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pseudoporphyria].
    Kósa A; Mátyus J; Horkay I
    Orv Hetil; 1994 Jan; 135(1):25-7. PubMed ID: 7904742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Porphyria cutanea tarda in a long-term hemodialysis patient].
    Földes M; Kószó F; Kis E; Judák R; Dobozy A
    Hautarzt; 1996 Dec; 47(12):932-5. PubMed ID: 9081942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudoporphyria in a peritoneal dialysis patient.
    Velioglu A; Ergun T; Ozener C
    Perit Dial Int; 2015; 35(2):234-5. PubMed ID: 25904777
    [No Abstract]   [Full Text] [Related]  

  • 49. [Porphyria cutanea tarda in hemodialyzed patients].
    Suga C; Ikezawa Z
    Nihon Rinsho; 1995 Jun; 53(6):1484-90. PubMed ID: 7616666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients.
    Poh-Fitzpatrick MB; Sosin AE; Bemis J
    J Am Acad Dermatol; 1982 Jul; 7(1):100-4. PubMed ID: 7107989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hemodialysis-related porphyria cutanea tarda with small repeated phlebotomies.
    Riccioni N; Donati G; Soldani S; Scatena P; Arcabasso GD
    Nephron; 1987; 46(2):125-7. PubMed ID: 3600921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Porphyria cutanea tarda-like aspects in two prolonged hemodialysis patients (author's transl)].
    Korting GW
    Dermatologica; 1975; 150(1):58-61. PubMed ID: 1149913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pseudoporphyria in patients with kidney disease on hemodialysis].
    Mijailović B; Zecević R; Karadaglić D; Mladenović T; Cusić S; Butorajac J; Hrvacević R
    Vojnosanit Pregl; 1995; 52(6):591-3. PubMed ID: 8644486
    [No Abstract]   [Full Text] [Related]  

  • 54. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-acetylcysteine use for amelioration of aminoglycoside-induced ototoxicity in dialysis patients.
    Feldman L; Sherman RA; Weissgarten J
    Semin Dial; 2012; 25(5):491-4. PubMed ID: 22708712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Porphyria and pseudo-porphyria in hemodialyzed patients.
    Topi GC; D'alessandro Gandolfo L; de Costanza F; Cancarini GC
    Int J Biochem; 1980; 12(5-6):963-7. PubMed ID: 7450157
    [No Abstract]   [Full Text] [Related]  

  • 57. The Case ∣ A blistering problem in a hemodialysis patient. The Diagnosis | Porphyria cutanea tarda.
    Talmaci L; Davenport A; Burns A
    Kidney Int; 2010 Dec; 78(11):1195-6. PubMed ID: 21076458
    [No Abstract]   [Full Text] [Related]  

  • 58. Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria?
    Glynne P; Deacon A; Goldsmith D; Pusey C; Clutterbuck E
    Am J Kidney Dis; 1999 Jul; 34(1):155-60. PubMed ID: 10401031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients.
    Hsu SP; Chiang CK; Yang SY; Chien CT
    Nephron Clin Pract; 2010; 116(3):c207-16. PubMed ID: 20606481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Porphyria cutanea tarda during maintenance haemodialysis.
    Garcia Parrilla J; Ortega R; Pena ML; Rodicio JL; de Salamanca RE; Olmos A; Elder GH
    Br Med J; 1980 Jun; 280(6228):1358. PubMed ID: 7388543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.